[ASAP] Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy đź”— Access full article via ACS Journal of Medicinal ChemistryShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
